You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

oral risperidone

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Panic Disorder Trial (Hydroxyzine, Escitalopram Oxalate)

Not yet recruiting
  • Panic Disorder
  • (no location specified)
Feb 20, 2023

Breakthrough Symptoms With Long-Acting Injectable Medications

Not yet recruiting
  • Schizophrenia
  • Schizophrenia Relapse
  • Second Generation Long-Acting Injectable Antipsychotic Medications
  • (no location specified)
Jul 22, 2022

Schizophrenia, Psychotic Disorders, Mood Disorders Trial in United States (LY03010 156 mg treatment group, deltoid, LY03010 156

Recruiting
  • Schizophrenia
  • +11 more
  • LY03010 156 mg treatment group, deltoid
  • +3 more
  • Little Rock, Arkansas
  • +8 more
Apr 11, 2022

Schizophrenia, Treatment-resistant Schizophrenia, Side Effect Trial (Aripiprazole, Paliperidone)

Not yet recruiting
  • Schizophrenia
  • +6 more
  • (no location specified)
Sep 27, 2023

Schizophrenia, Antipsychotics, Long-Acting Injection Trial in Korea, Republic of (Abilify maintena)

Completed
  • Schizophrenia
  • +4 more
  • Abilify maintena
  • Chungju, Chungcheongbuk-do, Korea, Republic of
  • +26 more
Dec 16, 2021

Treatment-resistant Depression Trial in Toronto (Psilocybin 25 mg, Risperidone 1 MG, Placebo)

Not yet recruiting
  • Treatment-resistant Depression
  • Psilocybin 25 mg
  • +2 more
  • Toronto, Ontario, Canada
    Centre for Addiction and Mental Health
Feb 2, 2023

Psychosis Trial in Albuquerque (Lumateperone, Risperidone)

Recruiting
  • Psychosis
  • Albuquerque, New Mexico
    University of New Mexico
May 25, 2023

Periodontitis in Schizophrenic Patients

Completed
  • Schizophrenia Spectrum and Other Psychotic Disorders
  • Periodontal Diseases
  • antipsychotic drugs inducing hyperprolactinemia
  • Giza, Egypt
    Rania Hassan Shalby
Sep 10, 2023

A Study for Schizophrenia Relapse Prediction

Completed
  • Schizophrenia
  • Oral Antipsychotics (OAP)
  • Ahmedabad, India
  • +9 more
Feb 2, 2022

Antipsychotic-induced Weight Gain (AIWG) Trial in United States (Miricorlilant)

Active, not recruiting
  • Antipsychotic-induced Weight Gain (AIWG)
  • Bentonville, Arkansas
  • +33 more
Feb 14, 2022

Schizophrenia, Schizo-affective Disorder Trial in Hollywood (Risperidone Implant)

Completed
Has Results
  • Schizophrenia
  • Schizo-affective Disorder
  • Risperidone Implant
  • Hollywood, Florida
    Segal Institute for Clinical Research 1201 North 37th Avenue
Feb 6, 2020

Antipsychotic-induced Weight Gain (AIWG) Trial in United States (Miricorilant)

Active, not recruiting
  • Antipsychotic-induced Weight Gain (AIWG)
  • Bentonville, Arkansas
  • +24 more
May 2, 2022

Weight Gain, Autism Spectrum Disorder, Medication Side Effect Trial in Nashville (Comparison of Risperidone and Aripiprazole)

Recruiting
  • Weight Gain
  • +2 more
  • Comparison of Risperidone and Aripiprazole
  • Nashville, Tennessee
    Division of Developmental Medicine
Mar 10, 2022

The Goal of This Trial is to to Compare the Effect of Risperidone vs Aripiprazole in Terms of Change in Serum Glutathione Level

Not yet recruiting
  • The Goal of This Trial is to to Compare the Effect of Risperidone vs Aripiprazole in Terms of Change in Serum Glutathione Level
  • Risperidone, Aripiprazole
  • (no location specified)
May 11, 2023

Schizophrenia Trial in Salt Lake City (Standard of Care Oral antipsychotics, IM aripiprazole once monthly, No Treatment)

Completed
Has Results
  • Schizophrenia
  • Standard of Care Oral antipsychotics
  • +2 more
  • Salt Lake City, Utah
    University of Utah
Jan 26, 2021

Haloperidol, Advanced Cancer, Hyperactive Delirium Trial in Singapore (Haldol 2mg/ml oral solution, Olanzapine Actavis 5mg

Recruiting
  • Haloperidol
  • +3 more
  • Haldol 2mg/ml oral solution
  • Olanzapine Actavis 5mg orodispersible tablet
  • Singapore, Singapore
  • +2 more
May 6, 2022

Schizophrenia Trial in United States (ASP4345, , risperidone)

Completed
Has Results
  • Schizophrenia
  • Cerritos, California
  • +26 more
Apr 14, 2022

Schizophrenia, Negative Symptoms in Schizophrenia Trial in Shanghai (Agomelatine)

Recruiting
  • Schizophrenia
  • Negative Symptoms in Schizophrenia
  • Shanghai, China
    Shanghai Mental Health Center
Dec 9, 2022

Schizophrenia Trial in Aizuwakamatsu (MP-214, Risperidone)

Completed
Has Results
  • Schizophrenia
  • Aizuwakamatsu, Fukushima, Japan
    (unnamed)
Apr 8, 2021

Risperidone ISM® in Schizophrenia Patients Hospitalised Due

Not yet recruiting
  • Schizophrenia
  • Risperidone ISM
  • (no location specified)
Jul 28, 2022

Schizophrenia Trial in Sapporo, Seoul, Taipei (MP-214 3mg, MP-214 6mg, MP-214 9mg)

Completed
Has Results
  • Schizophrenia
  • MP-214 3mg
  • +4 more
  • Sapporo, Hokkaido, Japan
  • +2 more
Apr 8, 2021

Post-Operative Confusion Trial in Winnipeg (Intrathecal bupivacaine and morphine)

Recruiting
  • Post-Operative Confusion
  • Intrathecal bupivacaine and morphine
  • Winnipeg, Manitoba, Canada
    St. Boniface Hospital
May 9, 2022

Maternal And Infant Antipsychotic Study

Not yet recruiting
  • Antipsychotics
  • Pregnancy
  • (no location specified)
Sep 16, 2023

Huntington Disease, Chorea Trial in Rochester (Risperidone, BioStamp nPoint device)

Recruiting
  • Huntington Disease
  • Chorea
  • Rochester, New York
    URMC Neurology; 919 Westfall Rd, Building C, Suite 100
Nov 2, 2021

Drug-induced Liver Injury Trial in Frankfurt (Placebo, 2x 140 mg per day, 3x 280 mg per day)

Active, not recruiting
  • Drug-induced Liver Injury
  • Placebo
  • +3 more
  • Frankfurt, Hessia, Germany
  • +1 more
Nov 21, 2021